Abingworth LLP Molecular Templates, Inc. Transaction History

Abingworth LLP

  • $301 Million
  • Q4 2022

A detailed history of Abingworth LLP transactions in Molecular Templates, Inc. stock. As of the latest transaction made, Abingworth LLP holds 200,000 shares of MTEM stock, worth $26,000. This represents 0.02% of its overall portfolio holdings.

Number of Shares
200,000
Previous 200,000 -0.0%
Holding current value
$26,000
Previous $150,000 56.0%
% of portfolio
0.02%
Previous 0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
BUY
$6.44 - $14.21 $1.29 Million - $2.84 Million
200,000 New
200,000 $2.8 Million

Others Institutions Holding MTEM

# of Institutions
2
Shares Held
499K
Call Options Held
0
Put Options Held
0
View Full List

About Molecular Templates, Inc.

MTEM Quotes by TradingView
  • Ticker MTEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,351,600
  • Market Cap $7.33M
  • Description
  • Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...
More about MTEM
Track This Portfolio

Track Abingworth LLP Portfolio

Follow Abingworth LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abingworth LLP, based on Form 13F filings with the SEC.

News

Stay updated on Abingworth LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email